Latest Breaking News On - Lipigon pharmaceuticals ab - Page 1 : comparemela.com

DGAP-News: First subject dosed in Lipigon s phase I clinical study with antisense oligonucleotide candidate derived from Secarna Pharmaceutical s LNAplus™ technology platform

DGAP-News: Secarna Pharmaceuticals GmbH & Co. KG / Key word(s): Study First subject dosed in Lipigon’s phase I clinical study with antisense oligonucleotide candidate derived from Secarna Pharmaceutical’s LNAplus™ technology platform 31.05.2022 / 14:00 The issuer is solely responsible for th.

Anne hennecke brittney sojevaAlexander gebauerPlanegg martinsriedSecarna lnaplusLipigon pharmaceuticals abSecarna pharmaceuticals gmbh coMc servicesSwedish medical products agencySecarna pharmaceuticalsDistribution servicesSecarna pharmaceuticals gmbhSecarna pharmaceuticalFamilial chylomicronemia syndromeLipigon pharmaceuticalsDenali therapeuticsCorporate news

First subject dosed in Lipigon s phase I clinical study with antisense oligonucleotide candidate derived from Secarna Pharmaceutical s LNAplus™ technology platform

DGAP-News: Secarna Pharmaceuticals GmbH & Co. KG / Key word(s): StudyFirst subject dosed in Lipigon’s phase I clinical study with antisense oligonucleotide candidate derived from Secarna Pharmaceutical’s LNAplus™ technology platform 31.05.2022 / 14:00 The issuer is solely responsible for the content of this announce.

Anne hennecke brittney sojevaAlexander gebauerPlanegg martinsriedSecarna lnaplusLipigon pharmaceuticals abSecarna pharmaceuticals gmbh coMc servicesSwedish medical products agencySecarna pharmaceuticalsDistribution servicesSecarna pharmaceuticals gmbhSecarna pharmaceuticalFamilial chylomicronemia syndromeLipigon pharmaceuticalsDenali therapeuticsCorporate news

First Subject Dosed in Lipigon s Phase I Clinical Study with Antisense Oligonucleotide Candidate Derived from Secarna Pharmaceutical s LNAplus(TM) Technology Platform

First Subject Dosed in Lipigon s Phase I Clinical Study with Antisense Oligonucleotide Candidate Derived from Secarna Pharmaceutical s LNAplus(TM) Technology Platform
tennesseedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tennesseedaily.com Daily Mail and Mail on Sunday newspapers.

Anne hennecke brittney sojevaAlexander gebauerPlanegg martinsriedSecarna lnaplusLipigon pharmaceuticals abSecarna pharmaceuticals gmbh coMc servicesSwedish medical products agencySecarna pharmaceuticalsFamilial chylomicronemia syndromeSecarna pharmaceuticals gmbhLipigon pharmaceuticalsDenali therapeuticsUnited states wire group